| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |